See also this year's filing and all EDGAR filings for this company.
PDF Report 0001719406_2026_NRX_Pharmaceuticals_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001719406, NRX Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 8,892,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 2,718,000 |
| 2 | PropertyPlantAndEquipmentNet | 63,000 |
| 3 | remainder_Assets | 1,283,000 |
| 4 | LiabilitiesCurrent | 28,578,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 315,000 |
| 7 | CostOfGoodsAndServicesSold | 505,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 13,061,000 |
| 9 | ResearchAndDevelopmentExpense | 3,777,000 |
| 10 | remainder_Expenses | 106,000 |
| 11 | remainder_Revenues | 1,225,000 |
| 12 | remainder_NetIncome | -12,398,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 12,956,000 |
| 1 | Liabilities | 28,893,000 |
| 2 | Expenses | 17,449,000 |
| 3 | Revenues | 1,225,000 |
| 4 | StockholdersEquity | -15,937,000 |
| 5 | NetIncome | -28,622,000 |
| 6 | ComprehensiveNetIncome | -28,622,000 |
| 7 | BaseVar | 36,460,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -3.03 |
| 9 | EconomicCapitalRatio | 0.677 |
Edgar->Model Mapping
Feature Distribution
Change over Time
